Mobina Golmohammadi, MSc^1*, Danai Dima, MD², Maram Albayyadhi, PhD^1*, Azam Moradi, PhD^1*, Shahzad Raza, MD³ and Majid Jaberi-Douraki^4*

¹Kansas State University-Olathe, Olathe, KS
²Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁴Department of Mathematics, Kansas State University, 1DATA Consortium, Computational Comparative Medicine, Olathe, KS

Mégane Tanguay, MD^1,2, Jean Roy, MD^1,2, Jiandong Su, MSc^3*, Engin Gul, BSc, MBA^3*, Donna Reece, MD^3,4, Christopher P. Venner, MD⁵, Darrell White, MD⁶, Michael P. Chu, MD⁷, Victor H. Jimenez-Zepeda, MD⁸, Kevin Song, MD, FRCPC⁹, Arleigh McCurdy, MD, BSc¹⁰, Hira Mian, MD¹¹, Michael Sebag, MD, PhD¹², Debra Bergstrom, MD, BSc, FRCPC¹³, Julie Stakiw, MD, FRCPC¹⁴, Anthony Reiman, MD¹⁵, Rami Kotb, MD¹⁶, Muhammad Aslam, MD^17*, Rayan Kaedbey, MD¹⁸, Martha L Louzada, MD, MSc¹⁹ and Richard LeBlanc, MD, FRCPC^1,2

¹Université de Montréal, Montréal, QC, Canada
²Institut universitaire d’hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada
³Canadian Myeloma Research Group, Vaughan, ON, Canada
⁴Princess Margaret Cancer Centre, Toronto, ON, Canada
⁵BC Cancer – Vancouver Centre, University of British Columbia, Vancouver, BC, Canada
⁶Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada
⁷Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
⁸Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada
⁹BC Cancer Agency, Vancouver General Hospital, Vancouver, BC, Canada
¹⁰The Ottawa Hospital, Ottawa, ON, Canada
¹¹Juravinski Cancer Center, Hamilton, ON, Canada
¹²McGill University, Montréal, QC, Canada
¹³Memorial University of Newfoundland, St John’s, NF, Canada
¹⁴Saskatoon Cancer Centre, University of Saskatchewan, Saskatoon, SK, Canada
¹⁵Department of Oncology, Saint John Regional Hospital, Saint John, NB, Canada
¹⁶Cancer Care Manitoba, Winnipeg, MB, Canada
¹⁷Allan Blair Cancer Centre, Regina, SK, Canada
¹⁸Jewish General Hospital, Montréal, QC, Canada
¹⁹London Regional Cancer Center, London, ON, Canada

Jingyu Xu^1*, Wenqiang Yan^2*, Lingna Li^3*, Chenxing Du, MD^4*, Lugui Qiu⁵ and Gang An^6*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, TIANJIN, CHN
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, CHN
⁴Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin City, CHN
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁶State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China

Meral Beksac, MD¹, Tulin Tuglular, MD^2*, Francesca Gay, MD, PhD³, Roberto Mina, MD^3*, Eirini Katodritou, MD^4*, Ali Unal, MD^5*, Michele Cavo, MD^6*, Guner Hayri Ozsan, MD^7*, Vincent H.J. Van Der Velden, PhD^8*, H. Berna Beverloo, PhD^9*, Michael Vermeulen^10*, Mark van Duin, PhD^10*, Guldane Cengiz Seval, MD^11*, Omur Gokmen Sevindik, MD^11*, Serena Merante, MD^12*, Kyriaki Manousou, MSc^13*, Pieter Sonneveld, MD, PhD¹⁴, Elena Zamagni, MD, PhD^15,16* and Evangelos Terpos, MD, PhD¹⁷

¹Cebeci Yerleskesi Dikimevi, Ankara, Turkey
²Department of Internal Medicine, Marmara University, Istanbul, Turkey
³Division of Hematology 1, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
⁴Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
⁵Department of Hematology, Faculty of Medicine, Erciyes University, Melikgazi, Kayseri, Turkey
⁶Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy
⁷Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Dokuz Eylul University, Izmir, Turkey
⁸Erasmus MC, University Medical Center Rotterdam, Department of Immunology, Rotterdam, Netherlands
⁹Erasmus MC, University Medical Center Rotterdam, Department of Clinical Genetics, Rotterdam, Netherlands
¹⁰Erasmus MC, University Medical Center Rotterdam, Department of Hematology, Rotterdam, Netherlands
¹¹Department of Hematology, Ankara University Faculty Of Medicine Cebeci Hospital, Ankara, Turkey
¹²European Myeloma Network, Pavia, Italy
¹³Health Data Specialists, Dublin, Ireland
¹⁴Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹⁵Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy
¹⁶IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy
¹⁷Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece

Karthik Nath, MBBS, PhD¹, Tala Shekarkhand, MS^2*, Bruno Almeida Costa, MD³, David Nemirovsky, MS^4*, Andriy Derkach, PhD^4*, Noriko Nishimura, MD, PhD^5*, Tasmin Farzana, MPH^6*, Colin Rueda^2*, David Chung, MD, PhD^7,8,9, Heather Landau, MD^7,9,10, Oscar Boutros Lahoud^7,9,10, Michael Scordo^8,9,11, Gunjan L. Shah^8,10,12, Hani Hassoun, MD^2,9, Kylee H Maclachlan, MBChB, PhD^2,9, Neha Korde, MD^2,9, Urvi A Shah, MD^2,9, Carlyn Rose Tan, MD^13,14, Malin Hultcrantz, MD, PhD^2,9, Sergio A. Giralt, MD, FACP^8,9,15, Saad Z Usmani, MD^7,8,9,16, Zainab Shahid^13,17*, Sham Mailankody, MBBS^2,8,9 and Alexander Lesokhin, MD^14,18,19

¹Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Icahn School of Medicine, Mount Sinai Morningside, New York, NY
⁴Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁹Department of Medicine, Weill Cornell Medical College, New York, NY
¹⁰Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹²Department of Medicine, Weill Cornell Medical College, New York
¹³Department of Medicine, Weill Cornell Medicine, New York, NY
¹⁴Myeloma Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁵Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York
¹⁶Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁷Department of Infectious Disease, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁸Weill Cornell Medicine, New York, NY
¹⁹Division of Hematology and Oncology, Memorial Sloan Kettering Cancer Center, New York, NY

Sunil Lakhwani^1,2*, Laura Rosiñol, MD, PhD^3*, Noemi Puig, MD, PhD⁴, Miguel Angel Pico Picos, MD^5*, Laura Medina-González, MD^5*, Joaquin Martinez Lopez, PhD, MD^6*, Bruno Paiva^7*, Maria Teresa Cedena Romero, MD, PhD^8*, Albert Oriol^9*, Rafael Ríos, MD, PhD^10*, María Jesús Blanchard, MD^11*, Isidro Jarque^12*, Joan Bargay^13*, Jose Maria Moraleda, MD, PhD^14*, Estrella Carrillo-Cruz, MD^15*, Anna Maria Sureda Balari, MD, PhD¹⁶, Isabel Krsnik^17*, Esther Gonzalez Garcia, MD^18*, Luis Felipe Casado Montero, MD¹⁹, Josep Maria Marti Tutusaus^20*, Cristina Encinas Rodriguez^21*, Felipe De Arriba, MD, PhD^22*, Luis Palomera, MD, PhD^23*, Antonia Sampol Mayol^24*, Yolanda González-Montes, MD^25*, Cristina Motlló^26*, Javier De la Cruz, MD^27*, Rafael Alonso Fernández, MD^28*, Maria-Victoria Mateos²⁹, Joan Blade Creixenti^30*, Juan Jose Lahuerta Palacios^8*, Jesus San Miguel^7* and Miguel Teodoro Hernández Garcia, MD, PhD^2,5*

¹Hospital Universitario de Canarias, Sta.Cruz Tenerife, Spain
²Universidad de La Laguna, Tenerife, Spain
³Amyloidosis and Multiple Myeloma Unit, Department of Hematology, IDIBAPS, Hospital Clinic, Barcelona, Spain
⁴Hospital Universitario de Salamanca (HUSAL), IBSAL, IBMCC (USAL-CSIC), CIBERONC, Salamanca, Spain
⁵Hospital Universitario de Canarias, Tenerife, Spain
⁶Hospital Universitario 12 de Octubre, Madrid, Spain
⁷Cancer Center Clinica Universidad de Navarra, Centro de Investigación Médica Aplicada (CIMA), IDISNA, CIBER-ONC number CB16/12/00369 and CB16/12/00489, Pamplona, Spain
⁸Hospital Universitario 12 de Octubre, CIBER-ONC CB16/12/00369, CNIO, Madrid, Spain
⁹Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
¹⁰Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain
¹¹Hospital Universitario Ramon y Cajal, Madrid, Spain
¹²Hospital Universitario La Fe, Valencia, Spain
¹³Hospital Universitario Son Llàtzer. IdIsBa., Palma de Mallorca, Spain
¹⁴Hospital Clínico Universitario Virgen de la Arrixaca. IMIB-Pascual Parrilla. University of Murcia, Murcia, Spain
¹⁵Hospital Vírgen del Rocío, Seville, Spain
¹⁶Institut Catala D'Oncologia, Barcelona, Spain
¹⁷Hospital Puerta de Hierro, Madrid, Spain
¹⁸University Hospital Cabueñes, Gijón, Spain
¹⁹Hospital General Universitario de Toledo, Toledo, Spain
²⁰Hospital Universitari Mútua de Terrassa, Terrassa, Spain
²¹Hospital General Universitario Gregorio Marañón, IiSGM, Madrid, Spain
²²Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
²³Hospital Clinico Universitario Lozano Blesa, Instituto Investigacion Sanitaria Aragon, Zaragoza, Spain
²⁴Hospital Universitario Son Espases, Palma de Mallorca, Spain
²⁵Institut d'Oncologia Dr. Josep Trueta, Girona, Spain
²⁶Hospital Althaia, Xarxa Assistencial de Manresa,, Manresa, Spain
²⁷Hospital Universitario 12 De Octubre, Instituto De Investigación Sanitaria,, Madrid, Spain
²⁸Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
²⁹University Hospital of Salamanca/IBSAL/CIC/CIBERONC, Salamanca, Spain
³⁰Amyloidosis and Myeloma Unit, Department of Hematology, Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain

Gregorio Barila, MD, PhD^1*, Angela Grassi, PhD^2*, Concetta Conticello, MD^3*, Roberto Mina, MD^4*, Chiara Marcon, MD^5*, Francesca Fazio^6*, Claudio Salvatore Cartia, MD^7*, Martina Tinelli, MD^8*, Maria Livia Del Giudice^9*, Sofia Pilerci, MD^10*, Angelo Belotti, MD^11*, Anna Pascarella, MD^12*, Mariantonietta Tafuri, MD^13*, Serena Rocchi, MD^14*, Nicola Sgherza^15*, Giuseppe Mele^16*, Edoardo Scomazzon, MD^17*, Massimo Gentile, MD^18*, Marika Porrazzo, MD^19*, Norbert Pescosta, MD^20*, Anna Furlan, MD^21*, Massimiliano Arangio Febbo, MD^22*, Cristina Clissa, MD^8*, Andrea Casson, MD^23*, Rossella Ribolla, MD^11*, Antonio Maroccia, MD^12*, Chiara Lisi^6*, Enrica Antonia Martino, MD^18*, Ombretta Annibali, MD, PhD^13*, Gabriele Buda, MD, PhD⁹, Elisabetta Antonioli, MD^24*, Silvia Mangiacavalli, MD^25*, Alberto Tosetto, MD¹⁷, Pellegrino Musto, MD^15*, Francesca Gay, MD, PhD²³, Elena Zamagni, MD, PhD^14*, Maria Teresa Petrucci^6*, Francesco Di Raimondo, MD²⁶, Francesca Patriarca, MD^5* and Renato Zambello, MD^27*

¹Haematology, Ospedale dell’Angelo, Mestre-Venezia, Italy, Mestre-Venezia, Italy
²Clinical Research Unit, Veneto Institute of Oncology, IOV-IRCCS, Padova, Italy
³Division of Hematology, Azienda Policlinico-S.Marco, University of Catania, Catania, Italy
⁴Division of Hematology 1, AOU Città della Salute e della Scienza di Torino, University of Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy
⁵Hematology and Transplant Center Unit, Udine University Hospital, DAME, University of Udine, Udine, Italy
⁶Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Roma, Italy
⁷Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁸Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
⁹Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
¹⁰Hematology Unit, Careggi Hospital, Firenze, Italy
¹¹Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹²Hematology Unit, Azienda ULSS3 Serenissima, Ospedale dell'Angelo, Venezia, Italy
¹³Hematology and Stem Cell Transplantation Unit, University Campus Biomedico, Roma, Italy
¹⁴IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy
¹⁵Department of Precision and Regenerative Medicine and Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy
¹⁶Haematology and Stem Cell Transplant Unit, Ospedale Antonio Perrino, Brindisi, Italy
¹⁷Hematology Unit, San Bortolo hospital, Vicenza, Italy
¹⁸Department of Onco-Hematology, Hematology Unit AO of Cosenza, Cosenza, Italy
¹⁹Hematology Unit, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy
²⁰Ematologia e Centro TMO, Ospedale Centrale Bolzano, Bolzano, Italy
²¹Hematology Unit, Santa Maria di Ca' Foncello, Treviso, Italy
²²Onco Hematology Unit, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy
²³Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Italy
²⁴Department of Hematology, Careggi Hospital and University of Florence, Firenze, Italy
²⁵Department of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
²⁶Haematology, A.O.U. Policlinico “G. Rodolico-San Marco”, Catania, Italy
²⁷Department of Medicine (DIMED), Hematology and Clinical Immunology section, Padua University School of Medicine, Padova, Italy

Muhammad Kashif, PhD^1,2,3*, Yijie Zhou^2,3,4*, Vincent Luong, MD^2,4,5*, Katarina Uttervall, MD, PhD^2,4,5*, Gösta Gahrton, MD, PhD^2,4, Hareth Nahi, MD, PhD^2,4,6*, Evren Alici, MD, PhD^4,7 and Johan Lund, MD, PhD^2,4,5*

¹Department of Medicine, Karolinska Institutet, Huddinge, Sweden
²Center of Hematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden
³Department of Information Technology, Uppsala University, Uppsala, Sweden
⁴Department of Medicine, Karolinska Institutet, Stockholm, Sweden
⁵Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
⁶Department of Medicine, Institution for biomedicine and clinical science, Linköping, Sweden
⁷Center for Hematology and Regenerative Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden

Issam S. Hamadeh, Pharm.D.^1*, Tala Shekarkhand, MS^2*, Colin Rueda^2*, Ross Firestone, MD, PhD³, Alice Wang, Pharm.D.^1*, Neha Korde, MD², Malin Hultcrantz, MD, PhD², Alexander Lesokhin, MD², Sham Mailankody, MBBS², Hani Hassoun, MD², Urvi A Shah, MD², Kylee H Maclachlan, MBChB, PhD², Dhwani Patel, MD^2*, Gunjan L. Shah, MD^4*, Michael Scordo, MD^5*, Oscar Boutros Lahoud⁴, David Chung, MD, PhD⁴, Heather Landau, MD⁴, Sergio A. Giralt, MD, FACP⁴, Saad Z Usmani, MD³ and Carlyn Rose Tan, MD^3*

¹Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY
²Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Myeloma Service, Division of Hematologic Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Adult Bone Marrow Transplantation Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Wendy N. Erber, MD PhD^1,2, Thomas Mincherton, BSc (Hons)^1*, Stephanie Lam, MB BS^2,3*, Henry Hui, PhD^1*, Hun Sheng Chuah, MBBS^2,4*, Hasib Sidiqi^3* and Kathy Fuller, PhD^1*

¹School of Biomedical Sciences, University of Western Australia, Crawley, Australia
²PathWest Laboratory Medicine, Nedlands, Australia
³Fiona Stanley Hospital, Perth, Australia
⁴Royal Perth Hospital, Perth, Australia

Lucio Gordan, MD^1*, Rohan Medhekar, PhD^2*, Alex Z. Fu^3*, Abril Oliva Ramirez^4*, Nicolle Bonar, PhD, BScH^4*, Bao-Ngoc Nguyen, PharmD, MS^4*, Michaela Spence, BScH, MSc^4*, Rebecca McTavish, BSc, MSc^4*, Tim Disher, RN, PhD^4*, Shuchita Kaila^3* and Anjan J. Patel, MD¹

¹Florida Cancer Specialists & Research Institute, Gainesville, FL
²Real World Value and Evidence Oncology, Janssen Scientific Affairs, LLC, Horsham, PA
³Real World Value and Evidence Oncology, Janssen Scientific Affairs, LLC, Titusville, NJ
⁴Value & Evidence Division, Marketing and Market Access, EVERSANA, Burlington, ON, Canada

Emmanuel Varlet^1*, Elina Alaterre, PhD^1,2*, Morgane Thomas, PhD^1*, Hugues De Boussac, PhD^2*, Laure Vincent, MD^3*, Guillaume Cartron, MD, Ph-D^4,5*, Charles Herbaux, MD, PhD^6,7*, Caroline Bret, PhD, PharmD^8*, Laurie Herviou, PhD^1*, Anne Marie Martinez, PhD^1*, Christophe Hirtz, PhD^9*, Aurore Attina^9*, Jerome Vialaret, PhD^9*, Giacomo Cavalli, PhD^1*, Jerome Moreaux, PhD^1,10,11,12 and Sara Ovejero, PhD^1,12*

¹Institute of Human Genetics, CNRS, Montpellier, France
²Diag2tec, Montpellier, France
³Department of Clinical Hematology, Montpellier University Hospital Center, Montpellier, France
⁴Clinical Hematology Department, Montpellier University Hospital Center, Montpellier, France
⁵Dept. Biological Hematology, Montpellier University Hospital Center, Montpellier, FRA
⁶Faculty of Medicine, University of Montpellier, Montpellier, France
⁷Clinical Hematology Department, Montpellier University Hospital, MONTPELLIER, France
⁸Dept. Biological Hematology, CHU Saint Eloi Hospital, MONTPELLIER, France
⁹IRMB, Montpellier University Hospital Center, Montpellier, France
¹⁰Faculty of Medicine, University of Medicine, Montpellier, France
¹¹Institut Universitaire de France, Paris, France
¹²Laboratory for Monitoring Innovative Therapies, Department of Biological Hematology, Montpellier University Hospital Center, Montpellier, France

Simon McNamara^1*, Natalie Boytsov^2*, Peter Feng Wang, MD, PhD^2*, Maya Hanna, PhD^2*, Anjali Franco^3*, Benjamin Lewing^3*, Barth Kelly^3* and Joseph Tkacz^3*

¹GSK, Stevenage, Hertfordshire, United Kingdom
²GSK, Collegeville, PA
³Inovalon, Bowie, MD

Bachisio Ziccheddu^1*, Claudia Giannotta^2*, Mattia D'Agostino, MD^3*, Giuseppe Bertuglia^3*, Elona Saraci, MsC^4*, Stefania Oliva, MD, PhD^3*, Benjamin Diamond, MD⁵, Niccolò Bolli, MD^6*, Paolo Corradini, MD⁷, David Coffey, MD⁵, Ola Landgren, MD¹, Benedetto Bruno, MD, PhD³, Mario Boccadoro, MD³, Massimo Massaia⁸, Francesco Maura, MD⁹ and Alessandra Larocca, MD, PhD³

¹Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, Miami, FL
²Laboratory of Blood Tumor Immunology, Molecular Biotechnology Center “Guido Tarone”, Department of Molecular Biotechnology and Health Sciences, Università di Torino, Turin, Italy
³Myeloma Unit, Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Torino, Italy
⁴Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Torino, Italy
⁵Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁶U.O.C Ematologia, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy
⁷University of Milan and Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy
⁸Division of Hematology, Santa Croce e Carle Hospital, Cuneo, Italy
⁹Sylvester Comprehensive Cancer Center, Myeloma Division, University of Miami, PALMETTO BAY, FL

Wenqiang Yan^1*, Xuehan Mao^2*, David E. Mery, PhD³, Yan Xu, MD^4*, Weiwei Sui^4*, Shuhui Deng^5*, Dehui Zou^6*, John D Shaughnessy, Jr, PhD^7*, Kenneth C. Anderson, MD⁸, Fenghuang Zhan, MD, PhD⁹, Lugui Qiu⁴ and Gang An^4*

¹State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood, TIANJIN, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
³Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas For Medical Sciences, Little Rock, AR
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, CHN
⁶Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁷Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical sciences, Little Rock, AR
⁸Dana-Farber Cancer Institute, Harvard Medical School, The Jerome Lipper Multiple Myeloma Center, Boston, MA
⁹Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR

Jiao Lu^1,2*, Chengcheng Fu^1*, Jinlan Pan^1*, Zhao Zeng^1*, Jingjing Shang^3*, Song Jin^1*, Lingzhi Yan^3*, Zhiyu Zhang^1*, Hongying You^1*, Xiaolan Shi, MD, PhD^1*, Shuang Yan^1*, Weiqin Yao^1*, Jing Wang^3*, Yun Xu^4*, Chunxiao Wu^1*, Wanhui Yan^1*, Hongmiao Shen^1*, Yue Huang^1*, Xin Xiang^4*, Qian Wang^1*, Zhi Yan^3*, Xingyue Wu^1*, Qinrong Wang^1*, Lijun Wen, MD^5*, Suning Chen^1* and Depei Wu¹

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China
²Department of Haematology, Jingjiang People’s Hospital, the Seventh Affiliated Hospital of Yangzhou University, Jingjiang, Jiangsu, China
³National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University,, Suzhou, China
⁴Suzhou Hongci Blood Disease Hospital, Suzhou, China
⁵National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China

Jordan Snyder, PharmD^1,2*, Zain Alsaddi^2,3*, Omar Alkharabsheh, MBBS^2,4, Barry Paul, MD, MS^2,5, Forat Lutfi, MD¹, Nausheen Ahmed, MD^1,2*, Zahra Mahmoudjafari, PharmD^1,2*, Al-Ola Abdallah, MD^1,2 and Shebli Atrash, MD^2,5*

¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Jordan University of Science and Technology, Irbid, Jordan
⁴University of South Alabama Mitchell Cancer Institute, Mobile, AL
⁵Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC

Ankushi Sanghvi, MD¹, Sagar Patel, MD^2*, Dhairya Nanavaty, MD^3* and Ahmed Nadeem, MD⁴

¹Internal Medicine, St. Vincent Hospital, WORCESTER, MA
²Landmark Medical Center, Woonsocket, RI
³The Brooklyn Hospital Center, Brooklyn, NY
⁴Landmark Medical Center, North Smithfield, RI

Priyanka Venkatesh, MBBS^1,2, Ghena Khasawneh, MD^1,3*, Hamza Hashmi, MD^1,4*, Omar Alkharabsheh, MD^1,5*, Barry Paul, MD, MS^1,6, Barry S. Skikne, MD^1,7*, Zahra Mahmoudjafari, PharmD^1,7*, Nausheen Ahmed, MD^1,7, Al-Ola Abdallah, MD^1,7 and Shebli Atrash, MD^1,6*

¹US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
²Internal Medicine, The University of Kansas Medical Center, Kansas City, KS
³Jordan University of Science and Technology, Irbid, Jordan
⁴Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁵University of South Alabama, Mobile, AL
⁶Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁷Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS

Daisuke Ikeda^1*, Toshiki Terao^2*, Mitsuaki Oura^3*, Atsushi Uehara^3*, Rikako Tabata^3*, Kentaro Narita^3*, Masami Takeuchi^3*, Youichi Machida^4* and Kosei Matsue³

¹Division of Hematology/Oncology, Kameda Medical Center, Kamogawa-Shi, CHI, Japan
²Department of Hematology and Oncology, Okayama University Hospital, Okayama, JPN
³Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan
⁴Department of Radiology, Kameda Medical Center, Chiba, JPN

Mehmet H. Kocoglu, MD^1,2, Aaron P. Rapoport, MD³, Tim Luetkens, MD^3,4*, Etse Gebru, BS^3*, Destiny Omili^3*, Jean A. Yared, MD⁵, Nancy M. Hardy, MD^6,7, Soren M Bentzen, PhD^8*, Ashraf Z. Badros, MD^9,10 and Djordje Atanackovic, MD³

¹University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
²Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD
³University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁴Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD
⁵University of Maryland Marlene and Stewart Comprehensive Cancer Center, Baltimore, MD
⁶University of Maryland Medical Center, Baltimore, MD
⁷University of Maryland School of Medicine, Baltimore, MD
⁸Division of Biostatistics and Bioinformatics, Baltimore, USA, University of Maryland School of Medicine, Baltimore, MD
⁹University of Maryland Greenebaum Cancer Center, Baltimore, MD
¹⁰Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD

Arti Vaishnav, BS^1*, Abdullah Khan², Qiuhong Zhao, MS^2*, Naresh Bumma, MD³, Francesca Cottini, MD², Elvira Umyarova, MD², Nidhi Sharma, PhD^4*, Ashley E Rosko, MD², Don Benson, MD² and Srinivas Devarakonda, MD²

¹The Ohio State University College of Medicine, Columbus, OH
²The Ohio State University, Columbus, OH
³The Ohio State University Comprehensive Cancer Center, COLUMBUS, OH
⁴Division of Hematology, The Ohio State University Wexner Medical Center, Columbus, OH

Yujun Li^1*, Jiangbo Zhang^2*, Jianmei Xu^3*, Huimei Guo^3*, Jing Wang^4*, Songying Zhao^4*, Liyang Liu^2*, Hua Xue^5* and Yao Liu, PhD, MD⁶

¹Qianxinan people's hospital, XingYi, guizhou province, China
²Department of Hematology,Affiliated Hospital of Hebei University, Baoding, Hebei, China
³Affiliated Hospital of Hebei University, Baoding, China
⁴Affiliated Hospital of Hebei University, Baoding City, Hebei Province, CHN
⁵Affiliated Hospital of Hebei University, Baoding City, Hebei Province, China
⁶Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing, China

Andrew J Portuguese, MD¹, Min Fang, MD, PhD^1*, Sherilyn A. Tuazon^2*, Margot Pont^3*, Xiaoyu Qu, PhD^1*, Carolyn Shasha^1*, Melissa L Comstock^4*, Justina Lyons^1*, Gabriel Cole^5*, Evan W. Newell, PhD^1*, Emily Glynn, MD^6*, Lorinda Soma^7* and Damian J Green, MD⁴

¹Fred Hutchinson Cancer Center, Seattle, WA
²Bristol Myers Squibb, Seattle, WA
³CellPoint BV, a Galapagos company, Oegstgeest, Netherlands
⁴Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
⁵CellPoint Bio, Oegstgeest, Netherlands
⁶University of Washington, Seattle, WA
⁷Department of Pathology, City of Hope Medical Center, Duarte, CA

Semaje Testamark^1*, Allison Verbyla, MPH^2*, Myra Robinson, PhD^3*, Peter M. Voorhees, MD⁴ and Manisha Bhutani, MD⁴

¹Emory University School of Medicine, Atlanta, GA
²Department of Biostatistics and Data Sciences, Atrium Health Levine Cancer Institute, Charlotte, NC
³Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁴Department of Hematologic Oncology & Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC

Mingyuan Sun^1*, Junyuan Qi, MD^2*, Lugui Qiu³, Jie Jin, MD⁴, Xin Li, MD^5*, Yongqiang Wei, MD^6*, Guimin Zhang^7*, Xue Liu, MM^8* and Shaohong Yin, ME^9*

¹Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, CA, China
²Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
⁴Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁵The Third Xiangya Hospital of Central South University, Changsha, China
⁶Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China
⁷Lunan Pharmaceutical Group Co. LTD, Linyi, China
⁸Lunan Pharmaceutical Group Co., LTD, Linyi, China
⁹Lunan Pharmaceutical Group Co., Ltd., Linyi, China

Mads Harsløf^1*, Iman Chanchiri^2*, Trine Silkjær^3*, Ulf Christian Frølund^4*, Elena Manuela Teodorescu^5*, Kristina Buchardi Nielsen^6*, Per Ishøy Nielsen^7*, Per Trøllund Pedersen^8*, Katrine Fladeland Iversen^9*, Kirsten Grønbæk, MD, DMSc^10,11,12, Annette Vangsted^10*, Sigrun Thorsteinsdottir, MD, PhD¹³ and Agoston Gyula Szabo, MD^10,14

¹Dept. of Hematology, Rigshospitalet, Copenhagen, Denmark, Copenhagen, Denmark
²Department of Hematology, Odense University Hospital, Odense, Denmark
³Department of Hematology Aarhus University Hospital, Aarhus, Denmark
⁴Department of Hematology Zealand University Hospital, Roskilde, Denmark
⁵Department of Hematology Aalborg University Hospital, Aalborg, Denmark
⁶Department of Hematology Regionshospitalet Gødstrup, Gødstrup, Denmark
⁷Department of Hematology Esbjerg Hospital, Esbjerg, Denmark
⁸Department of Hematology Esbjerg Hospital, Esbjeg, Denmark
⁹Department of Hematology Vejle Hospital, Vejle, Denmark
¹⁰Department of Hematology, Rigshospitalet, Copenhagen, Denmark
¹¹Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
¹²Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
¹³Department of Hematology, Rigshospitalet, København, Copenhagen, Denmark
¹⁴Department of Hematology, Vejle Hospital, Humlebæk, Denmark, Denmark

Cesar Rodriguez, MD^1*, Aurore Perrot, MD, PhD², Paul G. Richardson, MD³, Thierry Facon, MD⁴, Ivan Spicka^5*, Albert Oriol^6*, Kenshi Suzuki, MD, PhD⁷, Edvan Crusoe, Edvan.Crusoe@ebserh.gov.br^8*, Ajai Chari, MD⁹, Nicole Armstrong^10*, Christina Tekle, PhD^10*, Marie-Laure Risse^11*, Thomas Martin, MD¹² and Philippe Moreau, MD, PhD^13*

¹Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
²CHU de Toulouse, IUCT-O, Université de Toulouse, UPS, Service d’Hématologie, Toulouse, France
³Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
⁴Department of Haematology, Lille University Hospital, Lille, France
⁵Charles University Hospital Kralovske Vinohrady, Prague, Czech Republic
⁶Catalan Institute of Oncology and Josep Carreras Institute, Hospital Germans Trias i Pujol, Badalona, Spain
⁷Myeloma/Amyloidosis Center, Japanese Red Cross Medical Center, Tokyo, Japan
⁸Hospital Universitário Professor Edgar Santos da Universidade Federal da Bahia (HUPES), Salvador, Brazil
⁹University of California, San Francisco, San Francisco, NY
¹⁰Sanofi, Cambridge, MA
¹¹Sanofi, R&D, Vitry-sur-Seine, France
¹²University of California, San Francisco, CA
¹³Hematology Clinic, University Hospital Hotel-Dieu, Nantes, France

Eirini Katodritou, MD^1*, Dimitra Dalampira, MD^2*, Sosana Delimpasi^3*, Ioannis Ntanasis-Stathopoulos, MD, PhD^4*, Frini Karaolidou^5*, Annita Ioanna Gkioka, MD^6*, Vasiliki Labropoulou^7*, Emmanouil Spanoudakis^8*, Theodora Triantafyllou, MD^9*, Maria Kotsopoulou^10*, Eyrydiki Michalis, MD^11*, Chrysanthi Vadikolia^12*, Theodosia Papadopoulou, MD^9*, Aggeliki Sevastoudi, MD^9*, Michael Michael, MD^13*, Aikaterini Daiou^9*, Aikaterini Pentidou^8*, Ioannis V Kostopoulos, Msc. PhD^14*, Vasiliki Palaska, MD^9,12*, Maria Gavriatopoulou, MD, PhD^4*, Marie-Christine Kyrtsonis, MD⁶, Evgenia Verrou^9*, Efstathios Kastritis, MD^4*, Meletios A. Dimopoulos, MD, PhD⁴ and Evangelos Terpos, MD, PhD¹⁵

¹Theagenion Cancer Hospital, Thessaloniki, Greece
²Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, AL, Greece
³General Hospital Evangelismos, Athens, Greece
⁴Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁵Department of Hematology and Bone Marrow Transplantation Unit, Evangelismos Hospital, Athens, Greece
⁶First Department of Propaedeutic Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece
⁷Department of Internal Medicine, Division of Hematology, University of Patras Medical School, Patra, Greece
⁸Department of Hematology, University Hospital of Alexandroupolis, Alexandroupolis, Greece
⁹Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece
¹⁰Department of Hematology, Metaxa Cancer Hospital, Piraeus, Greece
¹¹Department of Hematology, “G. Gennimatas” General Hospital, Athens, Greece
¹²Department of Hematology, 424 Military Hospital, Thessaloniki, Greece
¹³Hematology Department, Bank of Cyprus Oncology Center, Nicosia, Cyprus
¹⁴Department of Biology, National and Kapodistrian University of Athens, Athens, Greece
¹⁵Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Drosia, Attiki, Greece

Ben A Derman, MD¹, Tadeusz Kubicki^2*, Heidi Simmons, PhD³, Aimaz Afrough, MD^4*, Jeffrey A. Zonder, MD⁵, David L. Grinblatt, MD⁶, Larry D. Anderson Jr., MD, PhD⁷, Andrew Kin, MD⁸, Sunil Narula, MD^1*, Shayan Rayani, MD^9*, Sandeep Gurbuxani, MBBS PhD¹⁰, Theodore Karrison^2*, Ken Jiang^2*, Ajay Major, MD, MBA¹¹, Jennifer H Cooperrider², Allison P. Jacob, MSc¹² and Andrzej J Jakubowiak, MD, PhD⁹

¹Section of Hematology/Oncology, University of Chicago, CHICAGO, IL
²University of Chicago, Chicago, IL
³Adaptive Biotechnologies Corporation, Seattle, WA
⁴UT Southwestern Medical Center, Dallas, TX
⁵Karmanos Cancer Institute, Detroit, MI
⁶NorthShore University HealthSystem, Evanston, IL
⁷Hematologic Malignancies and Cellular Therapy, UT Southwestern Medical Center, Dallas, TX
⁸Karmanos Cancer Institute/Wayne State University, DETROIT, MI
⁹Section of Hematology/Oncology, University of Chicago, Chicago, IL
¹⁰Department of Pathology, University of Chicago, Chicago, IL
¹¹University of Colorado Cancer Center, Aurora, CO
¹²Medical Affairs, Adaptive Biotechnologies, Seattle, WA

Adolfo Aleman, MPA^1,2, Morgan Van Kesteren^3*, Ariel Kogan Zajdman^2*, Komal Srivastava^3*, Lucia Y Chen, MD^1,4*, Bhaskar Upadhyaya, PhD^1*, Jessica Nardulli^5*, Kseniya Serebryakova^2*, Katerina Kappes, BSc^2*, Hayley Jackson^3*, Charles Gleason^3*, Oliver Van Oekelen, MD, PhD², Carlos Cordon-Cardo, MD^6*, Ania Wajnberg, MD^7*, Florian Krammer, PhD^3*, Miriam Merad, MD, PhD^8*, Sundar Jagannath^9,10*, Viviana Simon, MD, PhD^3* and Samir Parekh, MD^{1,11,12,13,14}

¹Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
²Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
³Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁵Icahn School of Medicine at Mount Sinai, Department of Microbiology, New York, NY
⁶Department of Pathology, Icahn School of Medicine At Mount Sinai, NEW YORK, NY
⁷Department of Medicine, General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
⁸Mount Sinai, The Tisch Cancer Institute, Icahn School of Medicine, New York, NY
⁹Mount Sinai Medical Center, New York, NY
¹⁰Tisch Cancer Institute, Multiple Myeloma Division, Icahn School of Medicine at Mount Sinai, New-York, NY
¹¹Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
¹²Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
¹³Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁴Mount Sinai School of Medicine, New York, NY

Jordan Snyder, PharmD^1,2*, Razan Mansour^1,3*, Aytaj Mammadzadeh^1,4*, Hamza Hashmi, MD^1,5*, Aimaz Afrough, MD^1,6, Omar Alkharabsheh, MBBS^1,7, Barry Paul, MD, MS^1,8, Shebli Atrash, MD^1,8*, Muhammad Umair Mushtaq, MD^1,2, Barry S. Skikne, MD^1,2*, Nausheen Ahmed, MD^1,2* and Al-Ola Abdallah, MD^1,2

¹US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
³Internal Medicine, University of Kansas Medical Center, Kansas City, KS
⁴Division of Hematology/Oncology, Mayo Clinic, Rochester, MN
⁵Medical University of South Carolina, Charleston, SC
⁶Hematologic Malignancies and Cellular Therapy, University of Texas Southwestern Medical Center, Dallas, TX
⁷University of South Alabama Mitchell Cancer Institute, Mobile, AL
⁸Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC

Nadine Abdallah, MD¹, Paul DiZona^2*, Amanika Kumar^3*, Betsy LaPlant, MS^4*, Terri Menser^5*, Sarah Aug^6*, Megan Weivoda, PhD⁷, Joselle Cook, MBBS⁷, Francis Buadi, MD⁷, Suzanne R. Hayman, MD¹, Angela Dispenzieri, MD¹, Martha Lacy, MD^1*, Morie A Gertz, MD^1*, S. Vincent Rajkumar, MD^1* and Shaji Kunnathu Kumar, MD⁷

¹Mayo Clinic, Rochester, MN
²Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³Obstetrics and Gynecology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester, Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN
⁵Health Care Delivery Research, Mayo Clinic, Rochester, MN
⁶Hematology, Mayo Clinic, Rochester, MN
⁷Division of Hematology, Mayo Clinic, Rochester, MN

Lawrence Liu, MD^1*, Scott R. Goldsmith², Sheryl Leahey, FNP^3*, Carlos Gomez Luna^3*, Shawn Streeter, PharmD^3*, Adam Braun, MD¹, Nitya Nathwani, MD⁴, Michael Rosenzweig², Firoozeh Sahebi, MD^5*, Azra Borogovac, MD⁶, Jonathan Keats^2*, Myo Htut, MD⁷, Arnab Chowdhury^2*, Sanjeet Singh Dadwal, MD³, Amrita Krishnan, MD⁸ and Murali Janakiram, MD, MS⁹

¹City of Hope National Medical Center, Duarte, CA
²Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA
³City of Hope National Comprehensive Cancer Center, Duarte, CA
⁴Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope Comprehensive Cancer Center, Duarte, CA
⁵Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁶Hematology/HCT, City of Hope National Medical Center, Irvine, CA
⁷City of Hope Comprehensive Cancer Center, Duarte, CA
⁸Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Irvine, CA
⁹Department of Hematology & Hematopoietic Cell Transplantation, CIty of Hope, Duarte, CA

Yonghuai Feng, PhD^1*, Song Cao, PhD^2* and Lv Xiaoli^3*

¹Department of Hematology, The Affiliated Hospital of Zunyi University, zunyi, China
²Department of Anesthesiology, Affiliated Hospital of Zunyi Medical University, Zunyi, China, Zunyi, Guizhou, China
³Department of Hematology, Affiliated Hospital of Zunyi Medical University, Guizhou, China

Gayathri Ravi, MD, Susan Bal, MD, Kelly Godby, MD^*, Smith Giri, MD, MS^*, Clare Ubersax, BS^*, Abigail Tucker, MSPH^* and Luciano Costa, MD, PhD

University of Alabama at Birmingham, Birmingham, AL

Louis S. Williams, MD¹, Bardia Khosravi, MD, MPH^2*, Marko Velimirovic, MD³, Jack Khouri, MD⁴, Shahzad Raza, MD³, Sandra Mazzoni, DO⁵, Christy J. Samaras, DO¹, Hussein Awada^6*, Danai Dima, MD⁶, Jason Valent, MD¹ and Faiz Anwer, MD¹

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Radiology, Mayo Clinic, Rochester, MN
³Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
⁴Department of Medicine, Cleveland Clinic, Lerner College of Medicine of Case Western Reserve University, Cleveland, OH
⁵Department of Hematology and Medical Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, OH
⁶Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH

Gigi Nu Hoang Quy Ton^1*, Katharina Kriegsmann, MD, MBA^1*, Mohamed H.S. Awwad^1*, Axel Benner^2*, Uta Bertsch, MD^1,3*, Britta Besemer, MD^4*, Mathias Hänel, MD⁵, Roland Fenk, MD, PhD^6*, Jana Schlenzka, MD^1*, Markus Munder^7*, Jan Dürig^8*, Igor Wolfgang Blau, MD, PhD^9*, Stefanie Huhn, PhD^1*, Dirk Hose, MD, PhD¹, Anna Jauch, PhD^10*, Andreas Neubauer, MD¹¹, Niels Weinhold, PhD^12*, Christof Scheid, MD^13*, Roland Schroers, MD^14*, Ivana von Metzler, MD^15*, Aneta Schieferdecker^16*, Jörg Thomalla, MD^17*, Peter Reimer, MD^18*, Rolf Mahlberg^19*, Ullrich Graeven, MD^20*, Stephan Kremers^21*, Uwe Martens, MD^22*, Christian Kunz^23*, Manfred Hensel, MD^24*, Andrea Seidel-Glätzer^25*, Katja Weisel, MD¹⁶, Hans Salwender, MD^26*, Carsten Müller-Tidow, MD^1,3,27*, Marc S. Raab^1*, Hartmut Goldschmidt^3,12, Elias K. Mai, M.D.^12* and Michael Hundemer^1*

¹Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
²Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany
³National Center for Tumor Diseases Heidelberg, Heidelberg, Germany
⁴University Hospital of Tuebingen, Tuebingen, Germany
⁵Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
⁶Department of Hematology, Oncology and Clinical Immunology,, University Hospital Düsseldorf, Duesseldorf, Germany
⁷Third Department of Medicine, University Medical Center of the Johannes Gutenberg University, Mainz, Germany
⁸Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany
⁹Medical Clinic, Charité University Medicine Berlin, Berlin, Germany
¹⁰Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany
¹¹Department of Hematology, Oncology and Immunology, Phillips-University Marburg, Marburg, Germany
¹²Heidelberg Myeloma Center, Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
¹³Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany
¹⁴Knappschaftskrankenhaus Bochum, University Hospital Bochum, Bochum, Germany
¹⁵Department of Internal Medicine II, University Hospital Frankfurt a.M., Frankfurt am Main, Germany
¹⁶Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹⁷Hematology / Oncology Center, Koblenz, Germany
¹⁸Evang. Kliniken Essen-Mitte, Evang. Krankenhaus Essen-Werden, Essen, Germany
¹⁹Internal Medicine I, Hospital Mutterhaus der Borromäerinnen, Trier, Germany
²⁰Medical Clinic I, Hospital Maria Hilf GmbH, Mönchengladbach, Germany
²¹Hematology / Oncology Center, Lebach, Germany
²²Hematology, Oncology, Palliative Care, SLK Clinic Heilbronn, Heilbronn, Germany
²³Hematology and Oncology, Westpfalz-Klinikum, Kaiserslautern, Germany
²⁴Mannheimer Onkologie Praxis, Mannheim, Germany
²⁵Coordination Centre for Clinical Trials (KKS) Heidelberg, Heidelberg, Germany
²⁶Asklepios Tumorzentrum Hamburg, Asklepios Hospital Hamburg Altona and St. Georg, Hamburg, Germany
²⁷Molecular Medicine Partnership Unit (MMPU), University of Heidelberg and European Molecular Biology Laboratory (EMBL), Heidelberg, Germany, Heidelberg, Germany

Maximilian J Steinhardt, MD^1*, Patrick Eiring, PhD^2*, Cornelia Vogt^3*, Umair Munawar^4*, Seungbin Han^5*, Larissa Haertle^6,7*, Silvia Nerreter^3*, Eva Teufel^3*, Julia Mersi, MD^1*, Xiang Zhou^8*, Michael Hudecek, MD, PhD^1*, Joaquin Martinez-Lopez, MD, PhD^6*, Johannes M Waldschmidt, MD⁹, Hermann Einsele, MD, PhD^1*, Leo Rasche, MD^1*, Markus Sauer, PhD^2* and K. Martin Kortüm, MD^1*

¹Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
²Department of Biotechnology and Biophysics, University of Würzburg, Würzburg, Germany
³Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
⁴Department of Internal Medicine II, University Hospital of Wuerzburg, Wuerzburg, Germany
⁵Department of Internal Medicine II, University Hospital Würzburg, Wuerzburg, Germany
⁶Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, Madrid, Spain
⁷Department of Internal Medicine II, Department of Internal Medicine II, University Hospital WüRzburg, W, WüRzburg, Germany
⁸Department of Internal Medicine II, University Hospital Wuerzburg, WüRzburg, Germany
⁹Department of Internal Medicine II, University of Wuerzburg Medical Center, Wuerzburg, Germany

Allan Feng^1,2*, Michael V. Gonzalez^3*, Melanie Mumau^3*, Saishravan Shyamsundar^4*, Paul J. Utz, MD^1,2* and David C. Fajgenbaum, MD, MBA, MSc³

¹Department of Medicine, Stanford University School of Medicine, Stanford, CA
²Institute for Immunity, Transplantation, and Infection, Stanford University School of Medicine, Stanford, CA
³Center for Cytokine Storm Treatment & Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁴Center for Cytokine Storm Treatment & Laboratory, University of Pennsylvania, Philadelphia, PA

Charan Thej Reddy Vegivinti, MD, MBBS¹, Jaison Lawrence Alexander Santhi, MBBS^2*, Lawrence Liu, MD^3*, Praneeth Reddy Keesari, MD⁴, Rahul Thakur, MBBS⁵, M Bakri Hammami, MD⁶, Venkatesh Kapu, DM^7*, Sindhu Pericherla, MD, DM^8*, Murali Mohan reddy Gopireddy, MD^9*, Nagarathna Poojary, Pharm D^9*, Ananta Ghimire, MPH^10*, Nishi Shah, MBBS, MPH¹¹ and Murali Janakiram, MD, MS¹²

¹Department of Medicine, Jacobi Medical Center / Albert Einstein College of Medicine, Bronx, NY
²Department of Medicine, Government Sivagangai Medical College, Madurai, India
³City of Hope National Medical Center, Duarte, CA
⁴Department of Internal Medicine, Staten Island University Hospital, Staten Island, NY
⁵Department of Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁶Jacobi Medical Center, Bronx, NY
⁷Tata Memorial Centre, Mumbai, India
⁸Dept of Medical Oncology, Sri Venkateswara Institute of Medical Sciences, Tirupathi, India
⁹coGuide academy, Bangalore, India
¹⁰coGuide Academy, Bangalore, India
¹¹Department of Oncology, Montefiore Medical Center/ Albert Einstein College of Medicine, Bronx, NY
¹²Department of Hematology & Hematopoietic Cell Transplantation, CIty of Hope, Duarte, CA

Hoi Kei Lon^1*, Jennifer Hibma, PharmD^2*, Jason Williams^3*, Diane Wang, PhD^4*, David Gifondorwa^5*, Wei An Ma^3*, Lindsay King^6*, Umberto Conte, PharmD^7*, Akos Czibere^6* and Mohamed Elmeliegy^3*

¹Pfizer, Inc., San Diego
²Pfizer, San Diego, CA
³Pfizer, Inc., San Diego, CA
⁴Pfizer Inc., San Diego, CA
⁵Pfizer, Inc., Groton
⁶Pfizer, Inc., Cambridge, MA
⁷Pfizer, New York, NY

Carlyn Tan, MD¹, Neha Korde, MD¹, Andriy Derkach, PhD^2*, Malin Hultcrantz, MD, PhD¹, Kylee H Maclachlan, MBChB, PhD¹, Hani Hassoun, MD¹, Sham Mailankody, MBBS¹, Urvi A Shah, MD¹, Sridevi Rajeeve, MD¹, Dhwani Patel, MD^1*, Alexander Lesokhin, MD¹, Oscar Boutros Lahoud³, Gunjan L. Shah³, Michael Scordo³, David Chung, MD, PhD³, Heather Landau, MD³, Sergio A. Giralt, MD, FACP³, Craig C. Hofmeister, MD⁴, Jonathan L. Kaufman, MD⁴, Ajay K. Nooka, MD, MPH⁴, Saad Z Usmani, MD¹, Sagar Lonial, MD^4* and Nisha S. Joseph, MD⁴

¹Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
³Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA

Anup J Devasia, MD, DM^1,2*, Sahar Khan, FRCPath, MD^3*, Eshetu Atenafu, M.Sc, P. Stat^4*, Harjot Vohra, MD, CCRP, MLT^5*, Frédéric Larose, MD^6*, Donna Reece, MD⁵, Suzanne Trudel, MD, FRCPC⁷, A. Keith Stewart, MBChB⁸, Sita D. Bhella, MD, MSc^9*, Vishal Kukreti, MD, FRCP, MSc¹⁰, Chloe Yang, MD^9*, Rodger E. Tiedemann, MBChB, PhD¹¹, Anca Prica, MD, MSc^10*, Monica Monchis, BScHons, BScPA, CCPA^12*, Eugene Leung, CCPA, BScPA, RT(T)^12*, Christina Zeglinski, MN, NP^5*, Zubaida Mohamed, BSc, MN^5* and Christine Chen, MHPE, MD, FRCPC¹⁰

¹Princess Margaret Cancer Centre, Toronto, ON, CAN
²Department of Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
³Windsor Regional Cancer Centre, Windsor, ON, CAN
⁴Biostatistics, University Health Network, Toronto, ON, CAN
⁵Princess Margaret Cancer Centre, Toronto, ON, Canada
⁶Department of Hematology & Oncology, Hotel-Dieu-de-Levis Hospital, Québec, QC, CAN
⁷Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁸Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁹Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
¹⁰Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada
¹¹Department of Medical Oncology and Hematology, Princess Margaret Hospital University Heath Network, Toronto, ON, Canada
¹²Department of Medical Oncology & Haematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Lucia Y Chen, MD^1,2*, Santiago Thibaud, MD^1*, Ajai Chari, MD¹, Joshua Richter, MD³, Hearn Jay Cho, MD⁴, Larysa J Sanchez, MD¹, Cesar Rodriguez, MD^1*, Adriana C Rossi, MD, MSc¹, Shambavi Richard, MD¹, Samir Parekh, MD¹ and Sundar Jagannath, MD¹

¹Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
²Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
³Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Tisch Cancer Institute, New York, NY

Naser Ansari-Pour, PhD^1*, Mohammad Kazeroun^1*, Evie Fitzsimons^2*, Selina J Chavda, MBBS, BSc, MRCP^3*, Alessandro Lagana, PhD⁴, Erin Flynt, PhD^5*, Udo Oppermann, PhD^1*, Karthik Ramasamy^1,6, Kwee Yong^7,8, Sarah Gooding^6,9* and Anjan Thakurta, PhD¹

¹Oxford Translational Myeloma Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, United Kingdom
²Cancer Institute, University College London, London, United Kingdom
³University College London, London, GBR
⁴Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
⁵Bristol Myers Squibb, Summit, NJ
⁶Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
⁷Department of Haematology, University College London, London, United Kingdom
⁸University College London, London, United Kingdom
⁹MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

Rodrigo Fonseca, MD^1*, Mariano Arribas^2*, Gregory Ahmann², Janna C Castro^3*, Erin E Wiedmeier-Nutor, MD^2*, Linda Banovic Baughn, PhD⁴, P. Leif Bergsagel, MD⁵ and Rafael Fonseca, MD⁶

¹Internal Medicine, Mayo Clinic Arizona, Scottsdale, AZ
²Department of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, AZ
³Information Technology, Mayo Clinic Arizona, Phoenix, AZ
⁴Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN
⁵Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ
⁶Division of Hematology/Oncology, Mayo Clinic Arizona, Phoenix, AZ

Lauren Campbell, PhD^1*, Karthik Ramasamy² and Ross Sadler^1*

¹Immunology Laboratory, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
²Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

Santiago Thibaud, MD^1*, Jerrel Catlett, MS^2*, Saoirse Bodnar^3*, MD Babu Mia^4*, Ajai Chari, MD^3*, Joshua Richter, MD⁵, Hearn Jay Cho, MD⁶, Larysa J Sanchez, MD¹, Cesar Rodriguez, MD^1*, Adriana C Rossi, MD, MSc¹, Sundar Jagannath, MD¹, Shambavi Richard, MD¹ and Samir Parekh, MD¹

¹Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
²Graduate School Of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
³Icahn School of Medicine at Mount Sinai, New York, NY
⁴TISCH CANCER CENTER, Icahn School of Medicine at Mount Sinai, NEW YORK, NY
⁵Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁶Department of Medicine, Hematology and Medical Oncology, Tisch Cancer Institute, Tisch Cancer Institute, New York, NY

Niraj Neupane, MD^1*, Arnav Srivastava^1*, Aditya Sanjeevi, MD^1*, Shubham Agrawal, MD^2*, Amir Mahmoud, MD, MSc¹, Anish Shah^3*, Pravash Budhathoki^4*, Himal Kharel, MD^1*, Utsav Joshi, MBBS⁵ and Binod Dhakal, MD, MS^6,7*

¹Rochester General Hospital, Rochester, NY
²Mercy catholic medical center, Philadelphia
³Bronxcare Health System, Mahottari, Nepal
⁴Bronxcare Health System, Bronx, NY
⁵Moffitt Cancer Center, Tampa
⁶BMT and Cellular Therapy, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁷BMT and Cellular Therapy, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee

Dhruvkumar Gadhiya, MBBS, MD¹, Vishrant Amin^2*, Yashkumar Kamani^3*, Gaganapalle Mahesh^4*, Kopal Kotak^5*, Rani Ratheesh^6* and Hardik Dineshbhai Desai, MBBS^7*

¹Internal Medicine, St.Luke's University Health- Anderson Campus, Easton, PA
²vishrantamin1995@gmail.com, Valsad, India
³Cagayan State University, Philippines, Cagayan, Philippines
⁴UNIVERSITY OF PERPETUAL HELP SYSTEM DALTA ALABANG-PHILLIPINES, Las Pinas, Philippines
⁵Pandit Dindayal Upadhyay Medical College, Rajkot, rajkot, India
⁶Dr.MGR Medical University ,Chennai,India, Chennai, India
⁷Gujarat Adani Institute of Medical Sciences, Affiliated to K.S.K.V University, Bhuj, India, Bhuj, India